12 NF1 Germline and Somatic Mosaicism Ludwine Messiaen and Jing Xie 13 Deep Intronic NF1 Mutations and Possible Therapeutic Interventions...
|
|
- Terence Adrian Simon
- 5 years ago
- Views:
Transcription
1 Contents 1 von Recklinghausen Disease: 130 Years... 1 Vincent M. Riccardi 2 Clinical Diagnosis and Atypical Forms of NF Sirkku Peltonen and Minna Pöyhönen 3 Management and Treatment of Complex Neurofibromatosis Rosalie E. Ferner and Susan M. Huson 4 Mortality in Neurofibromatosis Gareth R. Evans 5 The Cognitive Profile of NF1 Children: Therapeutic Implications Natalie A. Pride and Kathryn N. North 6 Clinical Expression of NF1 in Monozygotic Twins Elizabeth K. Schorry and Emily Sites 7 Value of Whole Body MRI in Patients with NF Victor-Felix Mautner 8 Quality of Life in NF Patricia Birch and J.M. Friedman 9 NF1 Gene: Promoter, 5 0 UTR, and 3 0 UTR Hua Li and Margaret R. Wallace 10 The Germline Mutational Spectrum in Neurofibromatosis Type 1 and Genotype Phenotype Correlations David N. Cooper and Meena Upadhyaya 11 Splicing Mechanisms and Mutations in the NF1 Gene Marco Baralle and Diana Baralle xiii
2 xiv Contents 12 NF1 Germline and Somatic Mosaicism Ludwine Messiaen and Jing Xie 13 Deep Intronic NF1 Mutations and Possible Therapeutic Interventions Conxi Lázaro, Juana Fernández-Rodríguez, and Eduard Serra 14 NF1 Microdeletions and Their Underlying Mutational Mechanisms Hildegard Kehrer-Sawatzki and David N. Cooper 15 The Somatic Mutational Spectrum of the NF1 Gene Meena Upadhyaya, Nadia Chuzhanova, and David N. Cooper 16 Relationship Between NF1 and Constitutive Mismatch Repair Deficiency Katharina Wimmer 17 Insights into NF1 from Evolution Britta Bartelt-Kirbach and Dieter Kaufmann 18 Modifier Genes in NF Eric Pasmant, Dominique Vidaud, and Pierre Wolkenstein 19 Dissection of Complex Genetic and Epigenetic Interactions Underlying NF1 Cancer Susceptibility Using Mouse Models Georgette N. Jones and Karlyne M. Reilly 20 Neurofibromin: Protein Domains and Functional Characteristics Klaus Scheffzek and Stefan Welti 21 Molecular Basis of Bone Abnormalities in NF David A. Stevenson and Florent Elefteriou 22 NF1-Associated Optic Glioma Anne C. Solga and David H. Gutmann 23 Molecular Basis of Cardiovascular Abnormalities in NF Brian K. Stansfield, David A. Ingram, Simon J. Conway, and Jan M. Friedman 24 Molecular Basis of Glomus Tumours Hilde Brems, Eric Legius, and Douglas R. Stewart 25 Pheochromocytoma and NF Birke Bausch and Hartmut P.H. Neumann 26 Molecular and Cellular Basis of Human Cutaneous Neurofibromas and Their Development Juha Peltonen, Eeva-Mari Jouhilahti, and Sirkku Peltonen
3 Contents xv 27 Somatic Copy Number Alterations: Gene and Protein Expression Correlates in NF1-Associated Malignant Peripheral Nerve Sheath Tumors Meena Upadhyaya and David N. Cooper 28 Pathologic and Molecular Diagnostic Features of Peripheral Nerve Sheath Tumors in NF Anat Stemmer-Rachamimov and G. Petur Nielsen 29 Malignant Peripheral Nerve Sheath Tumors: Prognostic and Diagnostic Markers and Therapeutic Targets Holly Meany, Brigitte C. Widemann, and Nancy Ratner 30 NF1 Mutations in Hematologic Cancers Tiffany Chang and Kevin Shannon 31 Legius Syndrome: Diagnosis and Pathology Hilde Brems, Ludwine Messiaen, and Eric Legius 32 The RASopathies: Syndromes of Ras/MAPK Pathway Dysregulation William E. Tidyman and Katherine A. Rauen 33 Advances in NF1 Animal Models and Lessons Learned Ophélia Maertens and Karen Cichowski 34 Drosophila: An Invertebrate Model of NF James A. Walker, Jean Y. Gouzi, and André Bernards 35 Zebrafish Model for NF Arun Padmanabhan and Jonathan A. Epstein 36 Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications Johanna Buchstaller, D. Wade Clapp, Luis F. Parada, and Yuan Zhu 37 Molecular and Cellular Approaches to Cognitive Impairments Associated with NF1 and Other Rasopathies Yong-Seok Lee and Alcino J. Silva 38 Ras Signaling Pathway in Biology and Therapy of Malignant Peripheral Nerve Sheath Tumors Faris Farassati 39 MicroRNA and NF1 Tumorigenesis Adrienne M. Flanagan and Nadège Presneau 40 Translational/Clinical Studies in Children and Adults with Neurofibromatosis Type Bruce Korf, Brigitte Widemann, Maria T. Acosta, and Roger J. Packer
4 xvi Contents 41 The Role of NF1 Lay Foundations: Future Vision Kim Hunter-Schaedle 42 Social Stigma in Neurofibromatosis Joan Ablon 43 Personalized Medicine in NF David Viskochil 44 Neurofibromatosis Type 1: Future Directions (Where Do We Go from Here?) Luis F. Parada Index
5
PRELIMINARY PROGRAM (as per 24 April 2018)
PRELIMINARY PROGRAM (as per 24 April 2018) FRIDAY - 2 NOVEMBER 2018 13:30-15:30 EDUCATIONAL SYMPOSIUM (Part 1) Clinical Dusica Babovic-Vuksanovic, MD Mimi Berman, MD Karin Cunha, PhD 13:30-15:30 ANIMAL
More informationPROGRAM (as of September 2018)
PROGRAM (as of September 2018) FRIDAY - 2 NOVEMBER 2018 08:30-12:30 OPTIONAL SATELLITE SYMPOSIUM Developing Therapeutics for Cutaneous Neurofibromas Sponsored by the Neurofibromatosis Therapeutics Acceleration
More informationNeurofibroma / Nerve Sheath Tumor
Dermal 95% Neurofibroma / Nerve Sheath Tumor Plexiform (PN) 25-40% Atypical (ANF) Unknown? MPNST 15.8% Appearance, pruritus Appearance, pain, function loss, Malignant transformation Loss of NF1 + CDKN2A/B
More informationNeurofibromatosis 1 (NF1) is an autosomal-dominant
Neuro-Oncology Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1 Victor-F. Mautner, Florence A. Asuagbor, Eva Dombi, Carsten Fünsterer, Lan Kluwe, Ralf Wenzel, Brigitte
More informationMini-Review. The Pathoetiology of Neurofibromatosis 1. Genetic Background. Neurofibromatosis 1 as a Clinical Entity
Mini-Review The American Journal of Pathology, Vol. 178, No. 5, May 2011 Copyright 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. DOI: 10.1016/j.ajpath.2010.12.056
More informationV. Neurofibromatosis Research Program
V. Neurofibromatosis Program Vision: To decrease the impact of neurofibromatosis. Mission: To promote research directed toward the understanding, diagnosis, and treatment of NF1 and NF2 and to enhance
More informationClinical presentations of 23 half-siblings from a mosaic neurofibromatosis type 1 sperm donor
Clin Genet 2016: 89: 346 350 Printed in Singapore. All rights reserved Short Report 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12600 Clinical presentations
More informationNeurofibromatosis, type 1. Fawn Leigh, M.D.
Neurofibromatosis, type 1 Fawn Leigh, M.D. Neurofibromatosis Types Neurofibromatosis type 1 1 in 3,000 Neurofibromatosis type 2 1 in 25,000 Schwannomatosis 1 in 40,000 Neurofibromatosis, type 1 Incidence
More informationMechanisms of Loss of Heterozygosity in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
ORIGINAL ARTICLE Mechanisms of Loss of Heterozygosity in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas Katharina Steinmann 1, Lan Kluwe 2, Reinhard E. Friedrich 2, Victor-Felix Mautner 2,
More informationNF1 Mutations and Clinical Manifestations in Neurofibromatosis Type 1 Patients in Tamil Nadu, South India
International Research Journal of Biological Sciences E-ISSN 2278-3202 Vol. 5(8), 38-44, August (2016) NF1 Mutations and linical Manifestations in Neurofibromatosis Type 1 Patients in Tamil Nadu, South
More informationNeurofibromatosis type 1: from genotype to phenotype
1 UMR745 INSERM, Université Paris Descartes, Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France 2 Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin,
More informationInfluence of Learning Disabilities on the Tumour Predisposition Syndrome NF1 Survey from Adult Patients Perspective
Influence of Learning Disabilities on the Tumour Predisposition Syndrome NF1 Survey from Adult Patients Perspective SOFIA GRANSTRÖM 1, REINHARD E. FRIEDRICH 2,3, ANNA KATHARINA LANGENBRUCH 4, MATTHIAS
More informationNeurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis
REVIEW Neurofibromatosis type 1-associated tumours: Their somatic al spectrum and pathogenesis Sebastian Laycock-van Spyk, Nick Thomas, David N. Cooper and Meena Upadhyaya * Institute of Medical Genetics,
More informationConstitutional NF1 Mutations In Neurofibromatosis 1 Patients With Malignant Peripheral Nerve Sheath Tumors
HUMAN MUTATION Mutation in Brief #664 (2003) Online MUTATION IN BRIEF Constitutional NF1 Mutations In Neurofibromatosis 1 Patients With Malignant Peripheral Nerve Sheath Tumors Lan Kluwe 1 *, Reinhard
More informationPhenotype GenotypeCorrelationinChildren with Neurofibromatosis Type 1
Original Article Phenotype GenotypeCorrelationinChildren with Neurofibromatosis Type 1 Christophe Barrea 1 Sandrine Vaessen 1 Saskia Bulk 2 Julie Harvengt 2 Jean-Paul Misson 1 1 Department of Pediatrics,
More informationClinical characterization of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
Clinical characterization of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions Victor-Felix Mautner, Lan Kluwe, Angelika C. Roehl, Simmone Bammert, David N Cooper,
More informationTechnical Advance. Detection and Characterization of NF1 Microdeletions by Custom High Resolution Array CGH
Technical Advance Journal of Molecular Diagnostics, Vol. 11, No. 6, November 2009 Copyright American Society for Investigative Pathology and the Association for Molecular Pathology DOI: 10.2353/jmoldx.2009.090064
More informationNeurofibromatosis type 1 and RASopathies
Neurofibromatosis type 1 and RASopathies Dawn Siegel, MD Medical College of Wisconsin American Academy of Dermatology San Diego, CA February 19 th, 2018 Neurofibromatosis Type 1 NF1- diagnostic criteria
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Neurofibromatosis File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_neurofibromatosis 4/2016 7/2017 7/2018 1/2018 Description
More informationNeurofibromatosis type 1 and malignancy in childhood
Clin Genet 2016: 89: 341 345 Printed in Singapore. All rights reserved Short Report 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12625 Neurofibromatosis
More informationN eurofibromatosis type 1 (NF1) is an autosomal
1of5 ELECTRONIC LETTER Evaluation of genotype-phenotype correlations in neurofibromatosis type 1 B Castle, M E Baser, S M Huson, D N Cooper, M Upadhyaya... N eurofibromatosis type 1 (NF1) is an autosomal
More informationREBECCA L. LODA-HUTCHINSON
ANALYSIS OF NF1 MUTATION MECHANISMS By REBECCA L. LODA-HUTCHINSON A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE
More informationPolyclonal rabbit anti-neurofibromin: PcNFn27, Monoclonal rabbit antineurofibromin:
Project title/type PI/contact Tool category Tool Description/Features Tool Status Publications Funded by NTAP Ras Reference Reagents Initiative Dominic Esposito Reagent Collection of entry clones (both
More informationEstratègies terapèutiques per la Neurofibromatosi de tipus 1
Estratègies terapèutiques per la Neurofibromatosi de tipus 1 Joan Castellsagué Garcia Aquesta tesi doctoral està subjecta a la llicència Reconeixement 3.0. Espanya de Creative Commons. Esta tesis doctoral
More informationMEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)
Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)
More informationTITLE: Genetic and Epigenetic Differences in Monozygotic Twins with NF1
AD AWARD NUMBER: W81XWH-10-1-0867 TITLE: Genetic and Epigenetic Differences in Monozygotic Twins with NF1 PRINCIPAL INVESTIGATOR: Elizabeth K. Schorry, M.D. CONTRACTING ORGANIZATION: Cincinnati Children's
More informationThe Spectrum of NF1 Mutations in Korean Patients with Neurofibromatosis Type 1
J Korean Med Sci 2006; 21: 107-12 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences The Spectrum of NF1 Mutations in Korean Patients with Neurofibromatosis Type 1 Neurofibromatosis type 1
More informationNon-optic glioma in adults and children with neurofibromatosis 1
Sellmer et al. Orphanet Journal of Rare Diseases (2017) 12:34 DOI 10.1186/s13023-017-0588-2 RESEARCH Non-optic glioma in adults and children with neurofibromatosis 1 Laura Sellmer 1*, Said Farschtschi
More informationNeurofibromatosis 1 PRACTICAL GENETICS
(2007) 15, 131 138 & 2007 Nature Publishing Group All rights reserved 1018-4813/07 $30.00 www.nature.com/ejhg PRACTICAL GENETICS In association with predisposes affected individuals to the development
More informationNe u r o f i b r o m at o s i s Type 1 is a common autosomal
Neurosurg Focus 28 (1):E8, 2010 Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications Or e n N. Go t t f r i e d, M.D., 1 Dav i d H. Vi s k o c h i l, M.D., Ph.D.,
More informationPERSPECTIVES. Neurofibromatosis type 1 a model for nervous system tumour formation? Joshua B. Rubin and David H. Gutmann
OPINION Neurofibromatosis type 1 a model for nervous system tumour formation? Joshua B. Rubin and David H. Gutmann Abstract Neurofibromatosis type 1 (NF1) is a common genetic condition in which affected
More information126 novel mutations in Italian patients with neurofibromatosis type 1
ORIGINAL ARTICLE 126 novel mutations in Italian patients with neurofibromatosis type 1 Donatella Bianchessi 1,a, Sara Morosini 1,a, Veronica Saletti 2, Maria Cristina Ibba 1, Federica Natacci 3, Silvia
More informationSpinal Neurofibromatosis without Café-au-Lait Macules in Two Families with Null Mutations of the NF1 Gene
Am. J. Hum. Genet. 69:1395 1400, 2001 Report Spinal Neurofibromatosis without Café-au-Lait Macules in Two Families with Null Mutations of the NF1 Gene Dieter Kaufmann, 1 Ralf Müller, 1 Britta Bartelt,
More informationCurrent status and recommendations for biomarkers and biobanking in neurofibromatosis
Current status and recommendations for biomarkers and biobanking in neurofibromatosis C. Oliver Hanemann, MD, PhD Jaishri O. Blakeley, MD Fabio P. Nunes, MD, MMSc Kent Robertson, MD Anat Stemmer- Rachamimov,
More informationThe neurofibromatoses: more than just a medical curiosity
PAPER 2006 Royal College of Physicians of Edinburgh The neurofibromatoses: more than just a medical curiosity SM Huson Honorary Consultant Clinical Geneticist, Regional Genetics Service, St Mary s Hospital,
More informationNeurofibromatosis 2 (NF2) is an autosomal dominant disease. Empirical development of improved diagnostic criteria for neurofibromatosis 2 ARTICLE
ARTICLE Empirical development of improved diagnostic criteria for neurofibromatosis 2 Michael E. Baser, PhD 1, Jan M. Friedman, MD, PhD 2, Harry Joe, PhD 3, Andrew Shenton, BSc 4, Andrew J. Wallace, PhD
More informationMEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)
Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with receipt) Saliva (OGR-575 DNA Genotek;
More informationA search for evidence of somatic mutations in the NF1 gene
44 Institute of Medical Genetics, University College of Medicine of Wales, Heath Park, CardiV CF4 4XN, UK AMJohn M Upadhyaya Department of Paediatric Neurology, Paediatric Clinic, University of Catania,
More informationThe epigenetic differences between. neurofibromas and malignant peripheral nerve. sheath tumours
Page 1 The epigenetic differences between neurofibromas and malignant peripheral nerve sheath tumours A thesis submitted to the University College London (UCL) for the degree of Doctor of Philosophy By
More informationUpdate on Genetic Testing for Melanoma
Update on Genetic Testing for Melanoma Emily Y. Chu, M.D., Ph.D. Assistant Professor of Dermatology & Pathology and Laboratory Medicine Hospital of the University of Pennsylvania February 18, 2018 AAD
More informationJMG Online First, published on June 28, 2013 as /jmedgenet Genotype-phenotype correlations
JMG Online First, published on June 28, 2013 as 10.1136/jmedgenet-2013-101648 Genotype-phenotype correlations 1 Genetic Medicine Research Group, Faculty of Medical and Human Sciences, Institute of Human
More informationTo cite this version: HAL Id: hal https://hal.archives-ouvertes.fr/hal
Cranial meningiomas in 411 NF2 patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset Miriam Jane Smith, Jenny E Higgs, Naomi L
More informationSTUDY. Pierre Wolkenstein, MD, PhD; Jacques Zeller, MD; Jean Revuz, MD; Emmanuel Ecosse, PhD; Alain Leplège, MD, PhD
Quality-of-Life Impairment in Neurofibromatosis Type 1 A Cross-sectional Study of 128 Cases STUDY Pierre Wolkenstein, MD, PhD; Jacques Zeller, MD; Jean Revuz, MD; Emmanuel Ecosse, PhD; Alain Leplège, MD,
More informationPlexiform Tumor of the Orbit
Plexiform Tumor of the Orbit Anat Stemmer-Rachamimov, MD Department of Pathology Massachusetts General Hospital Harvard Medical School Disclosure of Relevant Financial Relationships USCAP requires that
More informationRecent developments in neurofibromatosis type 1 Ming-Jen Lee a and Dennis A. Stephenson b
Recent developments in neurofibromatosis type 1 Ming-Jen Lee a and Dennis A. Stephenson b Purpose of review This review summarizes the recent clinical and genetic developments in neurofibromatosis type
More informationDeveloping therapies for Ras-driven tumors
Developing therapies for Ras-driven tumors Karen Cichowski, Ph.D. Harvard Medical School Ludwig Center at HMS Brigham and Women s Hospital Dana Farber/Harvard Cancer Center Disclosures: Genentech (Consultant)
More informationA Novel Deep Intronic Mutation Introducing a Cryptic Exon Causing Neurofibromatosis Type 1 in a Family with Highly Variable Phenotypes: A Case Study
ics: Current Research ISSN: 2161-1041 ics Svaasand et al., 2015, 4:3 DOI: 10.4172/2161- Case Report Open Access A Novel Deep Intronic Mutation Introducing a Cryptic Exon Causing Neurofibromatosis Type
More informationPerioperative Management of Neurofibromatosis Type 1
The Ochsner Journal 12:111 121, 2012 Ó Academic Division of Ochsner Clinic Foundation Perioperative Management of Neurofibromatosis Type 1 Charles J. Fox, MD,* Samir Tomajian, MD,* Aaron J. Kaye, à Stephanie
More informationA Storyboard Approach to Charting Research Progress and Demonstrating Impact. Naba Bora, Ph.D. The Congressionally Directed Medical Research Programs
The Congressionally Directed Medical Research Programs A Storyboard Approach to Charting Research Progress and Demonstrating Impact Naba Bora, Ph.D. Program Manager The views expressed in this presentation
More informationRole of Health Visitors in identifying signs of Neurofibromatosis type 1 (NF1)?
Role of Health Visitors in identifying signs of Neurofibromatosis type 1 (NF1)? My name is Dr Carly Jim I am a Senior Lecturer at Manchester Metropolitan University (MMU) and one of the Trustees of the
More informationMEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)
Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with
More informationCase Report Familial Lymphoproliferative Malignancies and Tandem Duplication of NF1 Gene
Case Reports in Oncological Medicine, Article ID 685857, 4 pages http://dx.doi.org/10.1155/2014/685857 Case Report Familial Lymphoproliferative Malignancies and Tandem Duplication of NF1 Gene Gustavo Fernandes,
More informationHealth Supervision for Children With Neurofibromatosis
CLINICAL REPORT Health Supervision for Children With Neurofibromatosis Guidance for the Clinician in Rendering Pediatric Care Joseph H. Hersh, MD, and the Committee on Genetics ABSTRACT Neurofibromatosis
More informationTITLE: Tibial Bowing and Pseudarthrosis in Neurofibromatosis Type 1
AWARD NUMBER: W81XWH-11-1-25 TITLE: Tibial Bowing and Pseudarthrosis in Neurofibromatosis Type 1 PRINCIPAL INVESTIGATOR: Dr. David Stevenson CONTRACTING ORGANIZATION: University of Utah SALT LAKE CITY,
More informationIntroduction. Overview
Neurofibromatosis type 1 Wendy Sherman MD (Dr. Sherman of Feinberg School of Medicine at Northwestern University in Chicago, Illinois, has no relevant financial relationships to disclose.) Jeffrey J Raizer
More informationDeletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification
800 MUTATION REPORT Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification A De Luca, I Bottillo, M C Dasdia, A Morella, V Lanari, L Bernardini, L Divona, S Giustini,
More informationMortality associated with neurofibromatosis type 1: A study based on Italian death certificates ( )
RESEARCH Open Access Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006) Maria Masocco 1*, Yllka Kodra 2, Monica Vichi 1, Susanna Conti 1, Mark Kanieff
More informationCase Report A Very Rare Assocıatıon; Coexıstence of Breast Cancer, Pheochromocytoma and Neurofıbromatosıs Type 1 in a Female Patıent
IBIMA Publishing International Journal of Case Reports in Medicine http://www.ibimapublishing.com/journals/ijcrm/ijcrm.html Vol. 2013 (2013), Article ID 511990, 6 pages DOI: 10.5171/2013.511990 Case Report
More informationD escriptions of individuals purported to have. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 REVIEW
81 REVIEW Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 Rosalie E Ferner, Susan M Huson, Nick Thomas, Celia Moss, Harry Willshaw, D Gareth Evans, Meena Upadhyaya,
More informationGamsızkan M, Kantarcıoglu CS, Yılmaz I, Yalcinkaya U, Sungur MA, Buyucek S, Onal B
Tykhe, from Konuralp/Duzce TERT promoter mutation and HER2 gene amplification in malignant peripheral nerve sheath tumours: is there a molecular signature playing role in malignant transformation? Gamsızkan
More informationNF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype
NF microdeletions in neurofibromatosis type : from genotype to phenotype Eric Pasmant, Audrey Sabbagh, Gill Spurlock, Ingrid Laurendeau, Elisa Grillo, Marie-Josée Hamel, Ludovic Martin, Sébastien Barbarot,
More informationNEUROFIBROMATOSIS TYPE 1: FROM GENE TO POPULATION AND CANCER. Elina Uusitalo
NEUROFIBROMATOSIS TYPE 1: FROM GENE TO POPULATION AND CANCER Elina Uusitalo TURUN YLIOPISTON JULKAISUJA ANNALES UNIVERSITATIS TURKUENSIS Sarja - ser. D osa - tom. 1339 Medica - Odontologica Turku 2018
More informationNF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
HUMAN MUTATION Mutation in Brief 31: E1506-E1516 (2010) Online MUTATION IN BRIEF NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype HUMAN MUTATION OFFICIAL JOURNAL www.hgvs.org
More informationStudying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy
Kavya Puchhalapalli CALS Honors Project Report Spring 2017 Studying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy Abstract Malignant brain tumors including medulloblastomas and primitive neuroectodermal
More informationV. Neurofibromatosis Research Program
V. Neurofibromatosis Research Program advancing laboratory research to the clinic Vision: To decrease the impact of neurofibromatosis and schwannomatosis. Mission: To promote research directed toward the
More informationInt J Clin Exp Pathol 2015;8(5): /ISSN: /IJCEP Shogo Tajima 1, Kenji Koda 2
Int J Clin Exp Pathol 2015;8(5):5113-5120 www.ijcep.com /ISSN:1936-2625/IJCEP0007009 Original Article A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component
More informationA prospective study of neurofibromatosis type 1 cancer incidence in the UK
British Journal of Cancer (2006) 95, 233 238 All rights reserved 0007 0920/06 $30.00 www.bjcancer.com A prospective study of neurofibromatosis type 1 cancer incidence in the UK L Walker 1, D Thompson 2,
More informationClinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1
Corsello et al. Italian Journal of Pediatrics (2018) 44:45 https://doi.org/10.1186/s13052-018-0483-z RESEARCH Open Access Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis
More informationNeurofibromatosis (NF) Center
Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington
More informationMRC-Holland MLPA. Description version 30; 06 June 2017
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are
More informationNeurofibromatosis 1 Prevalence in Children Aged 9 11 Years, Pinar del Río Province, Cuba
Neurofibromatosis 1 Prevalence in Children Aged 9 11 Years, Pinar del Río Province, Cuba Miladys Orraca MD PhD, Griselda Morejón MS, Niurka Cabrera MS, Reinaldo Menéndez MD MS, Odalys Orraca MD MS ABSTRACT
More informationComprehensive Testing for neurofibromatoses, RASopathies, and tuberous sclerosis at UAB
Medical Genomics Laboratory Department of Genetics Noonan syndrome/nsml Costello syndrome Cardio-facio-cutaneous syndrome Neurofibromatosis type 1 Legius syndrome Comprehensive Testing for neurofibromatoses,
More informationNon-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions
Mußotter et al. BMC Medical Genetics 2012, 13:98 RESEARCH ARTICLE Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions Tanja Mußotter 1, Lan Kluwe 2,3, Josef
More informationMRC-Holland MLPA. Description version 29; 31 July 2015
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082
More informationNeurological complications of neurofibromatosis type 1 in adulthood
Brain (1999), 122, 473 481 Neurological complications of neurofibromatosis type 1 in adulthood A. Créange, 1,2,6 J. Zeller, 2,3 S. Rostaing-Rigattieri, 2,4 P. Brugières, 2,5 J.-D. Degos, 1 J. Revuz 3 and
More informationEpidermal growth factor receptor expression in neurofibromatosis type 1 related tumors and NF1 animal models
Epidermal growth factor receptor expression in neurofibromatosis type 1 related tumors and NF1 animal models Jeffrey E. DeClue, 1 Sue Heffelfinger, 2 Giovanna Benvenuto, 1 Bo Ling, 3 Shaowei Li, 1 Wen
More informationImaging in neurofibromatosis type 1: An original research article with focus on spinal lesions
Original Research Article Imaging in neurofibromatosis type 1: An original research article with focus on spinal lesions Kalpesh Patel 1*, Siddharth Zala 2, C. Raychaudhuri 3 1 Assistant Professor, 2 1
More informationGrowth in North American white children with neurofibromatosis 1 (NF1)
J Med Genet 2000;37:933 938 933 Department of Medical Genetics, The University of British Columbia, 222-6174 University Boulevard, Vancouver, BC V6T 1Z3, Canada J Szudek P Birch J M Friedman Correspondence
More informationNeurofibromatosis Network Advocacy Program. NF Network Advocacy Program. Structure your Congressional meeting
Neurofibromatosis Network Advocacy Program NF Network Advocacy Program Structure your Congressional meeting Structure Your Congressional Meeting Introduction & Thank you Explain NF Impact Personal Story
More informationMEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors Walter J. Jessen,, Timothy P. Cripe, Nancy Ratner J Clin Invest. 2013;123(1):340-347. https://doi.org/10.1172/jci60578. Research
More informationMRC-Holland MLPA. Description version 08; 18 November 2016
SALSA MLPA probemix P122-D1 NF1 AREA Lot D1-1016. As compared to lot C2-0312, four probes in the NF1 area and one reference probe have been removed, four reference probes have been replaced and several
More informationWorld Journal of Colorectal Surgery
World Journal of Colorectal Surgery Volume 3, Issue 2 2013 Article 16 Neurofibroma of the anorectal canal presenting with diarrhoea and pelvic pain: Report a Case Waheeb Radman Al-Kubati Leila Ghaharamani
More informationLiving with Neurofibromatosis Type 1: A Guide for Adults
Living with Neurofibromatosis Type 1: A Guide for Adults by Linda Piersall, M.S. David H. Gutmann, M.D., Ph.D. Neurofibromatosis Program St. Louis Children s Hospital St. Louis, Missouri Rosalie Ferner,
More informationTAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions
ONCOLOGY REPORTS 32: 1347-1354, 2014 TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions Gun-Hoo Park 1,2*,
More informationComprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS
Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1
More informationINTERNATIONAL SYMPOSIUM ON NEW DEVELOPMENTS IN NEUROFIBROMATOSES AND RASOPATHIES
INTERNATIONAL SYMPOSIUM ON NEW DEVELOPMENTS IN NEUROFIBROMATOSES AND RASOPATHIES Their Management, Diagnosis, Current and Future Therapeutic Targets 27 th - 29 th November 2017, Crowne Plaza, Kochi, Kerala,
More informationBackground Principles and Technical Development
Contents Part I Background Principles and Technical Development 1 Introduction and the Nature of Radiosurgery... 3 Definitions of Radiosurgery... 5 Consequences of Changing Definitions of Radiosurgery...
More informationSpindle Cell Carcinoma: A Rare Malignant Transformation in Neurofibromatosis (NF1): A Case Study
JMSCR Volume 2 Issue 6 Page 1294-1298 June www.jmscr.igmpublication.org Impact Factor 1.1147 ISSN (e)-2347-176x Abstract Spindle Cell Carcinoma: A Rare Malignant Transformation in Neurofibromatosis (NF1):
More informationNew insights in the molecular pathogenesis of neurofibromatosis type 1. Ophélia Maertens
New insights in the molecular pathogenesis of neurofibromatosis type 1 Ophélia Maertens Ghent University, Faculty of Medicine and Health Sciences Center for Medical Genetics New insights in the molecular
More informationCarcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Major Principles (cont d) 4. Principle targets of genetic damage: 4 classes
More informationGenetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation- Dependent Probe Amplification analysis
Wu-Chou et al. Journal of Biomedical Science (2018) 25:72 https://doi.org/10.1186/s12929-018-0474-9 RESEARCH Open Access Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing
More informationThe Neurofibromatoses. Part 2: NF2 and Schwannomatosis
DIAGNOSIS AND TREATMENT REVIEW The Neurofibromatoses. Part 2: NF2 and Schwannomatosis Christine Lu-Emerson, MD,* Scott R. Plotkin, MD, PhD *Department of Neurology, University of Washington, Seattle, WA;
More informationMolecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1
Thomas et al. Human Genomics 2012, 6:18 PRIMARY RESEARCH Open Access Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1 Laura Thomas 1, Victor-Felix
More informationCutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study
Cannon et al. Orphanet Journal of Rare Diseases (2018) 13:31 https://doi.org/10.1186/s13023-018-0772-z RESEARCH Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study
More informationGenotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more
450 Med Genet 98;:450-455 Department of Medical Genetics, St Mary's Hospital, Manchester M13 OJH, UK D G R Evans A Wallace University Department of Human Genetics, Newcastle University, Newcastle upon
More information1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to
More informationU University. The Cognitive Dysfunction and Skeletal Dysplasias of NF1: Are We Ready for Clinical Trials? Neurofibromatosis Type 1
The Cognitive Dysfunction and Skeletal Dysplasias of NF1: Are We Ready for Clinical Trials? John C. Carey Division of Medical Genetics, Department of Pediatrics U University of Utah Genetics and Wiley
More informationMultiple tumours of peripheral nerves are often
Multiple schwannomas in the peripheral nerves Akira Ogose, Tetsuo Hotta, Tetsuro Morita, Hiroshi Otsuka, Yasuharu Hirata From Niigata Cancer Centre Hospital and Niigata University, Japan Multiple tumours
More informationRESEARCH ARTICLE. Human Mutation
RESEARCH ARTICLE Human Mutation OFFICIAL JOURNAL Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH www.hgvs.org Carles Garcia-Linares,
More informationNF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
INTERNATIONAL JOURNAL OF ONCOLOGY 42: 657-666, 2013 NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
More information